Profitability Ratios
| Ratio |
Value |
| GP Margin |
52.0% |
| EBIT Margin |
10.5% |
| EBITDA Margin |
18.4% |
| Operating Margin |
10.5% |
| Pretax Margin |
38.5% |
| Cont. Ops Margin |
29.4% |
| Net Margin |
29.4% |
| Bottom Line Margin |
29.4% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
5.62 |
| Quick Ratio |
4.19 |
| Solvency Ratio |
0.309 |
| Cash Ratio |
1.03 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.08 |
| Forward PEG |
-0.08 |
| Price/Book |
1.11 |
| Price/Sales |
3.20 |
| Price/FCF |
22.05 |
| Price/Op Cash Flow |
15.52 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1448 |
| Debt/Equity |
0.2054 |
| Debt/Capital |
0.1704 |
| Long-Term Debt/Capital |
0.1523 |
| Financial Leverage |
1.42 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
1.04 |
| Operating Cash Flow Ratio |
1.029 |
| Operating Cash Flow/Sales |
20.6% |
| Free Cash Flow/Operating Cash Flow |
70.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.77 |
| Interest Coverage |
5.5204 |
| Short-Term Operating Cash Flow Coverage |
14.04 |
| Operating Cash Flow Coverage |
0.35 |
| Capital Expenditure Coverage |
3.38 |
| Dividend + Capital Expenditure Coverage |
3.38 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
94.75 |
| EPS |
27.873 |
| Debt/Share |
57.9540 |
| Cash/Share |
56.59 |
| Book Value/Share |
273.40 |
| Tangible BV/Share |
245.74 |
| Equity/Share |
273.40 |
| Operating Cash Flow/Share |
19.521 |
| Capital Expenditure/Share |
5.781 |
| FCF/Share |
13.740 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.763 |
| Earnings Before Tax/EBIT |
3.680 |
| Price/Fair Value |
1.11 |
| Debt/Market Cap |
0.1667 |
| Effective Tax Rate |
23.7% |
| Enterprise Value Multiple |
19.46 |
BIO - Bio-Rad Laboratories, Inc.